Therapeutic Focus

TetraGenetics has established drug discovery and development programs targeting ion channels involved in the pathogenesis of autoimmunity and pain. In each case TetraGenetics is using its proprietary technology to discover and develop drug leads through both its antibody partnership and structural biology programs.